Exhibition

Alveolix aims to change the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs’ responses in humans than standard in-vitro and in-vivo models and, importantly, to reduce animal testing.

ATLAS Neuroengineering is a spin-off company of Imec (Leuven, BE) and IMTEK, University of Freiburg (DE) and originates from the successful European FP6 NeuroProbes project. ATLAS Neuroengineering has developed a system platform using an implantable device to record individual neurons for scientific understanding of cerebral systems and for the monitoring treatment of neurological disease.

The Brain Mind Institute at the EPFL is a research institution founded with the mission to understand the fundamental principles of brain function in health and disease by using and developing unique experimental, theoretical, and technological approaches.

Creaholic is a Swiss innovation-house, founded in 1986 by Elmar Mock, one of the co-inventors of the Swatch. Today, Creaholic is composed of a multidisciplinary team, having successfully completed more than 700 projects, originated 180 patent families and received numerous industry awards.

The disruptive and "hands-on" approach of Creaholic, enabling clients to improve their products and systems, to discover new technology applications and business opportunities, has been leveraged across various industrial fields from medical to packaging, and automation to watches. Creaholic works with leading industry partners as well as incubating its own ventures via licensing and establishment of spin-off companies such as Woodwelding, Bonewelding, miniswys, smixin and Joulia.

Frontiers is at the forefront of building this ultimate Open Science platform. By taking publishing entirely online, Frontiers drive innovations and develop new technologies to make peer-review more efficient and transparent, provide impact metrics for articles and researchers, is the first – and only – to merge open-access publishing with a research network platform, Loop, to catalyse collaboration and research dissemination and we popularize research to the public, including kids. Frontiers' mission is to increase the reach and impact of articles and their authors.

Frontiers is today one the largest and fastest-growing open-access publishers, receives millions of monthly page views, received the ALPSP Gold Award for Innovation in Publishing in 2014, has publishing agreements with many universities, and collaborates with Nature Publishing Group, Scientific American, Digital Science, OpenAire, CrossRef, OASPA, COPE, Jacobs Foundation, and others to advance Open Science worldwide.

Hocoma was set up in 2000, as a spin-off of the Swiss University Hospital Balgrist. The company currently employs more than 170 people at its headquarters in Volketswil near Zurich (Switzerland) and at its subsidiaries in the USA, Singapore and Slovenia. Hocoma is the global market leader for the development, manufacturing and marketing of robotic and sensorbased devices for functional movement therapy. Therapy solutions support the treatment of neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, cerebral palsy or other neurological diseases and injuries as well low back pain patients. The product range features devices for intensive gait therapy (Lokomat®), functional therapy of the upper extremities (Armeo®), patient mobilization in early rehabilitation programs (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo®) at home and at the clinic. Hocoma products are applied successfully in clinics and research institutes worldwide. The medical technology company has received many technology and entrepreneur awards, amongst others the “Swiss Technology Award” and the “Ernst&Young Entrepreneur of the Year” award. Hocoma generated a turnover of more than 30 million CHF in 2013. Dr. Gery Colombo is the CEO of Hocoma AG.

The Human Brain Project is a European Commission Future and Emerging Technologies Flagship that aims to achieve a multi-level, integrated understanding of brain structure and function through the development and use of information and communication technologies.

The International Brain Research Organization (IBRO) is a union of neuroscience organizations with the aim to promote and support neuroscience training and collaborative research around the world. More than 80 international, national and regional scientific organizations constitute IBRO's Governing Council, which together with the five IBRO Regional Committees launch the educational programs that reach young neuroscientists in need of support and assistance. In addition, IBRO has partnerships with like-minded federations of scientific societies to identify priorities and help bridge gaps in knowledge, investment and resources in the field of the brain and related diseases, from development to aging.

Nanoelectronics research center imec and its Dutch affiliate Holst Centre develop advanced wearable technologies, wireless health platforms and offer full system design for healthcare, wellness, and lifestyle applications, such as health wristbands, ECG health patches, EEG headsets and biomedical ICs.

Imec leverages its scientific knowledge with the innovative power of its global partnerships in ICT, healthcare and energy. Imec’s highly sensitive, intelligent, miniaturized, ultra-low power, wearable sensors enable comfortable, continuous, reliable and long-term monitoring and management of health in ambulatory conditions and daily-life activities.

INCF (International Neuroinformatics Coordinating Facility) develops and maintains database and computational infrastructure for neuroscientists. Software tools and standards for the international neuroinformatics community are being developed through the INCF Programs, which address infrastructural issues of high importance to the neuroscience community.

Currently there are 4 program areas: Digital Brain Atlasing, Ontologies for Neural Structures, Multi-scale modeling, and Standards for Data Sharing. More than 180 leading international researchers are involved in the programs. A cloud-based data federation - the INCF Dataspace - has been developed to enable collaboration between researchers through the sharing of neuroscience data, text, images, sounds, movies, models and simulations.

iniLabs invents, produces and sells neurotechnological products. It has a unique combination of technology and expertise in neuromorphic hardware design. Its products are in use at over 70 organizations including Fortune 500 companies and top-ranked universities worldwide, and it maintains a close R&D collaboration with the Institute of Neuroinformatics at the University of Zurich and the ETH Zurich. The flagship product of iniLabs, the Dynamic Vision Sensor, mimics human retinal function to achieve unprecedented performance in speed, dynamic range and power consumption. iniLabs partners with application developers in many in fields including robotics, automotive, industrial vision and healthcare. A recent highlight is the development of a novel sensor for enabling visually impaired persons to navigate independently, with intuitive usability and long battery life.

Invest Saint Lucia's dedicated team of professionals offer guidance and direction to new and established investors who are interested in pursuing investment opportunities in Saint Lucia.

These services include:

• Providing general and sector specific information
• Facilitating investor site visits and providing customised information packages
• Matching investors with sector-specific projects
• Introducing potential investors to local industry
• Business startup facilitation
• Identifying sites for business development
• Aftercare Client Support

Invest Saint Lucia manages seven industrial estates which house 26 factory shells in industrial parks strategically located throughout the island's economic hubs. This allows Invest Saint Lucia to provide the best rates for leasing property and factory spaces thus making business set-up easier.

MindMaze is a spin off from the Swiss Federal Institute of Technology (EPFL) and in less than three years has become one of the top 10 healthcare start-ups in Switzerland. The company brings together an eclectic mix of computer scientists, neuroscientists, physicists and roboticists driven by a passion to enhance the quality of life of brain injury survivors. In less than three years the MindMaze team has developed and launched medical grade virtual reality (VR) products to stimulate neural recovery. MindMaze is now translating our VR and neuroscience expertize into new fields of consumer health and technology.

NeuroPro is a Swiss medical research, design and commercialisation company that brings together cutting-edge mobile computing and innovative signal analysis methodologies to create user-friendly, real-time solutions for consumers, researchers and healthcare professionals.

NeuroPro’s mission is to harness the benefits of the digital and mobile revolutions and apply them to the problems of neuroscience to radically improve the way we acquire, understand and utilise brain signal data. NeuroPro’s unique technologies leverage proprietary systems and patents furthered by strategic partnerships with prominent research and technology providers.

Orrb was created to solve the issue of wellness and learning in the workplace. Orrb is a gymnasium for the mind, helping you relax, regain focus, increase performance and train for self-development. Content comes via Orrb X, the subscription account that puts a range of wellness and learning activities directly into your daily work schedule, depending on person mood or learning needs. Orrb believes that greater learning is achieved through greater self-awareness.

WISE Srl is developing a genuinely new generation of implantable leads for neuromodulation and neuromonitoring. WISE’s electrodes are highly biocompatible, foldable, stretchable, minimally invasive and cheaper to produce than existing products and will overcome the major limitations of today’s technology. They will improve the treatment of patients that are already profiting from neuromodulation, while at the same time expanding the use of neuromodulation to fields and clinical indications in which the complex technical demands cannot be met by the current technology.

The electrodes are produced through a proprietary innovative technology: the Supersonic Cluster Beam Implantation (SCBI), which allows the metallization of stretchable polymers. The SCBI technology has been protected by patents in Europe, USA, Israel, Canada, India, Japan and Korea. Alongside the IP, WISE holds a strong know-how on the technology and its implementation.

W Science is a private company that provides resources, technology and leadership to support initiatives that enable the integration and packaging of science with information technologies that advance personal healthcare and personal lifestyles.